Last updated on April 19, 2014 at 8:43 EDT

Technical Review on Rite Aid and CVS Caremark: Flu and Generic Introductions Key Threats

January 23, 2013

LONDON, January 23, 2013 /PRNewswire/ –

With the worst flu season in years getting even more intense, companies in the drug
stores industry, including CVS Caremark Corporation (NYSE:CVS) and Rite Aid Corporation
(NYSE:RAD), are doing what they can to help combat what has now become an epidemic.
StockCall analysts have released their latest technical research report on Rite Aid and
CVS Caremark which can be downloaded for free at http://www.stockcall.com/signup

Several companies have been working hard to keep up supplies of the vaccine, with Rite
Aid recently obtaining over 400,000 additional seasonal flu shots. With more people
receiving their shots daily, there is hope that the outbreak will soon subside. Register
today to access the free report on Rite Aid at http://www.StockCall.com/RAD012313.pdf

Elsewhere in the industry, companies have had their fair share of challenges dealing
with brand-name drug patent expirations and generic introductions. Generics have had a
negative effect on top-lines, and in some cases have also crimped margins. Cost-cutting
and streamlining initiatives have helped offset some of the declines, and it will be
interesting to see how individual companies have performed as earnings season gets into
full swing.

December results were mixed for industry players, as almost all companies were
negatively affected by generic introductions, while some also lost out due to adverse
weather. Rite Aid saw its December same store sales fall 2.2% when compared to the same
period last year, as generic introductions and lower front-end sales more than offset a
rise in flu-related shots and prescriptions.

CVS Caremark Corp. [Free Report on CVS [http://www.stockcall.com/CVS012313.pdf ]] [1],
on the other hand, fared better, posting a same store year-over-year December sales
increase of 1.8% from its CVS/pharmacy division. The company was ex-dividend yesterday,
Tuesday January 22nd, and it is set to release its quarterly readings on February 06th
before the market opens.


        1) CVS Caremark Corporation Technical Analysis [
          http://www.StockCall.com/CVSCaremarkCorporation012313.pdf ]

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the headlines. Sign up today to talk
to our financial analyst at http://www.stockcall.com

SOURCE StockCall.com

Source: PR Newswire